Stay updated on Canakinumab with Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Canakinumab with Docetaxel in NSCLC: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the Record History. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-24T11:15:24.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The Record History now shows a new revision entry Revision: v3.3.2 and the older Revision: v3.2.0 entry is removed. This update affects only the history metadata of the page, not the core trial information.
    Difference
    0.0%
    Check dated 2025-11-25T14:15:33.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-11-18T07:23:58.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Version 74 (posted 2023-08-16) updates the Study Status and Adverse Events sections. It also notes that Quality Control Review has not concluded.
    Difference
    0.0%
    Check dated 2025-10-27T20:51:56.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Major change: page now advertises a government operating status notice and updates the release version to v3.2.0; previous v3.1.0 label was removed.
    Difference
    7%
    Check dated 2025-10-06T08:00:21.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.
    Difference
    0.2%
    Check dated 2025-09-29T04:38:01.000Z thumbnail image

Stay in the know with updates to Canakinumab with Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.